| Literature DB >> 32697172 |
Osnat C Melamed1,2, Tanya S Hauck1,3, Leslie Buckley1,3, Peter Selby1,2,3,4, Benoit H Mulsant1,3.
Abstract
The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.Entities:
Keywords: COVID-19; addiction; alcohol; cannabis; clinical care; clinical research; cocaine; opioids; pandemic; substance use disorders; tobacco
Mesh:
Year: 2020 PMID: 32697172 DOI: 10.1080/08897077.2020.1784363
Source DB: PubMed Journal: Subst Abus ISSN: 0889-7077 Impact factor: 3.716